Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06383767
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-04-22
Brief Title:
A Phase III Study of ESG401 for Locally Advanced or Metastatic HRHER2- Breast Cancer
Sponsor:
Shanghai Escugen Biotechnology Co Ltd
Organization:
Shanghai Escugen Biotechnology Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords: